As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4916 Comments
531 Likes
1
Demeri
Regular Reader
2 hours ago
I hate that I’m only seeing this now.
👍 265
Reply
2
Adelen
Consistent User
5 hours ago
Early bullish signs may be tempered by afternoon profit-taking.
👍 25
Reply
3
Jaelany
Influential Reader
1 day ago
Looking for like-minded people here.
👍 216
Reply
4
Maisy
Elite Member
1 day ago
Really regret not checking earlier. 😭
👍 179
Reply
5
Rhondia
Daily Reader
2 days ago
Active rotation between sectors highlights the ongoing need for careful stock selection and diversification.
👍 218
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.